Akebia Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Akebia Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2017 to Q3 2024.
  • Akebia Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 210M shares, a 11.7% increase year-over-year.
  • Akebia Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 187M shares, a 2.56% increase from 2022.
  • Akebia Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 183M shares, a 10.1% increase from 2021.
  • Akebia Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 166M shares, a 19.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 210M +22M +11.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 210M +22.9M +12.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 205M +20.2M +10.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 187M +4.68M +2.56% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 188M +4.42M +2.41% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 187M +3.22M +1.75% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 185M +5.17M +2.88% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 183M +16.8M +10.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 184M +10.1M +5.81% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 184M +22.3M +13.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-28
Q1 2022 180M +25.8M +16.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 166M Oct 1, 2021 Dec 31, 2021 10-K/A 2023-08-28
Q3 2021 174M +30.5M +21.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 161M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 154M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q3 2020 143M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q4 2017 47.4M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-26
Q3 2017 46.9M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-26
Q2 2017 40.8M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-26
Q1 2017 38.8M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.